0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiovascular Prosthetic Products Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-32Y16915
Home | Market Reports
Global Cardiovascular Prosthetic Products Market Research Report 2024
BUY CHAPTERS

Global Cardiovascular Prosthetic Products Market Research Report 2026

Code: QYRE-Auto-32Y16915
Report
2026-04-10
Pages:158
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cardiovascular Prosthetic Products Market Size

The global Cardiovascular Prosthetic Products market was valued at US$ 31770 million in 2025 and is anticipated to reach US$ 56050 million by 2032, at a CAGR of 8.6% from 2026 to 2032.

Cardiovascular Prosthetic Products Market

Cardiovascular Prosthetic Products Market

Cardiovascular Prosthetic Products are implantable or external devices that replace or assist parts of the cardiovascular system, such as the heart, arteries, or veins. Examples of cardiovascular prosthetic devices include pacemakers, implanted heart valves, artificial vascular grafts, and stents. These devices significantly improve quality of life and are normally installed by a heart surgeon. They are also used to treat a number of cardiac conditions, including valvular heart disease, congenital heart defects, arrhythmias, coronary artery disease, and heart failure. Aortic aneurysm repair, valve replacement, endovascular stenting, ventricular assist devices, transcatheter aortic valve replacement (TAVR), and other procedures all involve these cardiovascular prosthetic devices.
According to report shared by Center for Disease Control and Prevention (CDC), in 2020, it was stated that, coronary heart disease is the most common type of heart disease, killing 382,820 people in U.S. Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) happen in adults less than 65 years old. Increase in number of cardiovascular surgeries is anticipated to drive the application of cardiovascular prosthetic devices and boosts market growth. For instance, according to National Library of Medicine in September 2022, it was reported that, more than 200,000 heart valve replacement surgeries are performed annually worldwide, with a predicted increment to 8,50,000 per year by 2050. In addition, according to National Library of Medicine in August 2022, almost 400,000 coronary artery bypass grafting (CABG) surgeries are performed each year making it the most-performed major surgical procedure.
This report delivers a comprehensive overview of the global Cardiovascular Prosthetic Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiovascular Prosthetic Products. The Cardiovascular Prosthetic Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cardiovascular Prosthetic Products market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cardiovascular Prosthetic Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cardiovascular Prosthetic Products Market Report

Report Metric Details
Report Name Cardiovascular Prosthetic Products Market
Accounted market size in 2025 US$ 31770 million
Forecasted market size in 2032 US$ 56050 million
CAGR 8.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Cardiac Prosthetic Products
  • Vascular Prosthetic Products
Segment by Application
  • Hospitals
  • Clinics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Biotronic, W. L. Gore & Associates, Inc, Artivion, Inc, Johnson and Johnson, Medtronic Plc, Meril Life Sciences Pvt. Ltd, Edwards Lifesciences, Terumo Group, Maquet Cardiovascular, Gore, Nicast, Bard, Jude Medical, LeMaitre Vascular, Lifetech Scientific, BiVACOR, SynCardia, Jarvik Heart, Inc, CARMAT, AbioMed
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Cardiovascular Prosthetic Products companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Cardiovascular Prosthetic Products Market growing?

Ans: The Cardiovascular Prosthetic Products Market witnessing a CAGR of 8.6% during the forecast period 2026-2032.

What is the Cardiovascular Prosthetic Products Market size in 2032?

Ans: The Cardiovascular Prosthetic Products Market size in 2032 will be US$ 56050 million.

Who are the main players in the Cardiovascular Prosthetic Products Market report?

Ans: The main players in the Cardiovascular Prosthetic Products Market are Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Biotronic, W. L. Gore & Associates, Inc, Artivion, Inc, Johnson and Johnson, Medtronic Plc, Meril Life Sciences Pvt. Ltd, Edwards Lifesciences, Terumo Group, Maquet Cardiovascular, Gore, Nicast, Bard, Jude Medical, LeMaitre Vascular, Lifetech Scientific, BiVACOR, SynCardia, Jarvik Heart, Inc, CARMAT, AbioMed

What are the Application segmentation covered in the Cardiovascular Prosthetic Products Market report?

Ans: The Applications covered in the Cardiovascular Prosthetic Products Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Cardiovascular Prosthetic Products Market report?

Ans: The Types covered in the Cardiovascular Prosthetic Products Market report are Cardiac Prosthetic Products, Vascular Prosthetic Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiovascular Prosthetic Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cardiac Prosthetic Products
1.2.3 Vascular Prosthetic Products
1.3 Market by Application
1.3.1 Global Cardiovascular Prosthetic Products Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiovascular Prosthetic Products Market Perspective (2021–2032)
2.2 Global Cardiovascular Prosthetic Products Growth Trends by Region
2.2.1 Global Cardiovascular Prosthetic Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cardiovascular Prosthetic Products Historic Market Size by Region (2021–2026)
2.2.3 Cardiovascular Prosthetic Products Forecasted Market Size by Region (2027–2032)
2.3 Cardiovascular Prosthetic Products Market Dynamics
2.3.1 Cardiovascular Prosthetic Products Industry Trends
2.3.2 Cardiovascular Prosthetic Products Market Drivers
2.3.3 Cardiovascular Prosthetic Products Market Challenges
2.3.4 Cardiovascular Prosthetic Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiovascular Prosthetic Products Players by Revenue
3.1.1 Global Top Cardiovascular Prosthetic Products Players by Revenue (2021–2026)
3.1.2 Global Cardiovascular Prosthetic Products Revenue Market Share by Players (2021–2026)
3.2 Global Top Cardiovascular Prosthetic Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cardiovascular Prosthetic Products Revenue
3.4 Global Cardiovascular Prosthetic Products Market Concentration Ratio
3.4.1 Global Cardiovascular Prosthetic Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular Prosthetic Products Revenue in 2025
3.5 Global Key Players of Cardiovascular Prosthetic Products Head Offices and Areas Served
3.6 Global Key Players of Cardiovascular Prosthetic Products, Products and Applications
3.7 Global Key Players of Cardiovascular Prosthetic Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cardiovascular Prosthetic Products Breakdown Data by Type
4.1 Global Cardiovascular Prosthetic Products Historic Market Size by Type (2021–2026)
4.2 Global Cardiovascular Prosthetic Products Forecasted Market Size by Type (2027–2032)
5 Cardiovascular Prosthetic Products Breakdown Data by Application
5.1 Global Cardiovascular Prosthetic Products Historic Market Size by Application (2021–2026)
5.2 Global Cardiovascular Prosthetic Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cardiovascular Prosthetic Products Market Size (2021–2032)
6.2 North America Cardiovascular Prosthetic Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cardiovascular Prosthetic Products Market Size by Country (2021–2026)
6.4 North America Cardiovascular Prosthetic Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiovascular Prosthetic Products Market Size (2021–2032)
7.2 Europe Cardiovascular Prosthetic Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cardiovascular Prosthetic Products Market Size by Country (2021–2026)
7.4 Europe Cardiovascular Prosthetic Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cardiovascular Prosthetic Products Market Size (2021–2032)
8.2 Asia-Pacific Cardiovascular Prosthetic Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cardiovascular Prosthetic Products Market Size by Region (2021–2026)
8.4 Asia-Pacific Cardiovascular Prosthetic Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cardiovascular Prosthetic Products Market Size (2021–2032)
9.2 Latin America Cardiovascular Prosthetic Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cardiovascular Prosthetic Products Market Size by Country (2021–2026)
9.4 Latin America Cardiovascular Prosthetic Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiovascular Prosthetic Products Market Size (2021–2032)
10.2 Middle East & Africa Cardiovascular Prosthetic Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cardiovascular Prosthetic Products Market Size by Country (2021–2026)
10.4 Middle East & Africa Cardiovascular Prosthetic Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Cardiovascular Prosthetic Products Introduction
11.1.4 Abbott Laboratories Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.1.5 Abbott Laboratories Recent Development
11.2 B Braun Melsungen AG
11.2.1 B Braun Melsungen AG Company Details
11.2.2 B Braun Melsungen AG Business Overview
11.2.3 B Braun Melsungen AG Cardiovascular Prosthetic Products Introduction
11.2.4 B Braun Melsungen AG Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.2.5 B Braun Melsungen AG Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Details
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Cardiovascular Prosthetic Products Introduction
11.3.4 Boston Scientific Corporation Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.3.5 Boston Scientific Corporation Recent Development
11.4 Biotronic
11.4.1 Biotronic Company Details
11.4.2 Biotronic Business Overview
11.4.3 Biotronic Cardiovascular Prosthetic Products Introduction
11.4.4 Biotronic Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.4.5 Biotronic Recent Development
11.5 W. L. Gore & Associates, Inc
11.5.1 W. L. Gore & Associates, Inc Company Details
11.5.2 W. L. Gore & Associates, Inc Business Overview
11.5.3 W. L. Gore & Associates, Inc Cardiovascular Prosthetic Products Introduction
11.5.4 W. L. Gore & Associates, Inc Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.5.5 W. L. Gore & Associates, Inc Recent Development
11.6 Artivion, Inc
11.6.1 Artivion, Inc Company Details
11.6.2 Artivion, Inc Business Overview
11.6.3 Artivion, Inc Cardiovascular Prosthetic Products Introduction
11.6.4 Artivion, Inc Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.6.5 Artivion, Inc Recent Development
11.7 Johnson and Johnson
11.7.1 Johnson and Johnson Company Details
11.7.2 Johnson and Johnson Business Overview
11.7.3 Johnson and Johnson Cardiovascular Prosthetic Products Introduction
11.7.4 Johnson and Johnson Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.7.5 Johnson and Johnson Recent Development
11.8 Medtronic Plc
11.8.1 Medtronic Plc Company Details
11.8.2 Medtronic Plc Business Overview
11.8.3 Medtronic Plc Cardiovascular Prosthetic Products Introduction
11.8.4 Medtronic Plc Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.8.5 Medtronic Plc Recent Development
11.9 Meril Life Sciences Pvt. Ltd
11.9.1 Meril Life Sciences Pvt. Ltd Company Details
11.9.2 Meril Life Sciences Pvt. Ltd Business Overview
11.9.3 Meril Life Sciences Pvt. Ltd Cardiovascular Prosthetic Products Introduction
11.9.4 Meril Life Sciences Pvt. Ltd Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.9.5 Meril Life Sciences Pvt. Ltd Recent Development
11.10 Edwards Lifesciences
11.10.1 Edwards Lifesciences Company Details
11.10.2 Edwards Lifesciences Business Overview
11.10.3 Edwards Lifesciences Cardiovascular Prosthetic Products Introduction
11.10.4 Edwards Lifesciences Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.10.5 Edwards Lifesciences Recent Development
11.11 Terumo Group
11.11.1 Terumo Group Company Details
11.11.2 Terumo Group Business Overview
11.11.3 Terumo Group Cardiovascular Prosthetic Products Introduction
11.11.4 Terumo Group Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.11.5 Terumo Group Recent Development
11.12 Maquet Cardiovascular
11.12.1 Maquet Cardiovascular Company Details
11.12.2 Maquet Cardiovascular Business Overview
11.12.3 Maquet Cardiovascular Cardiovascular Prosthetic Products Introduction
11.12.4 Maquet Cardiovascular Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.12.5 Maquet Cardiovascular Recent Development
11.13 Gore
11.13.1 Gore Company Details
11.13.2 Gore Business Overview
11.13.3 Gore Cardiovascular Prosthetic Products Introduction
11.13.4 Gore Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.13.5 Gore Recent Development
11.14 Nicast
11.14.1 Nicast Company Details
11.14.2 Nicast Business Overview
11.14.3 Nicast Cardiovascular Prosthetic Products Introduction
11.14.4 Nicast Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.14.5 Nicast Recent Development
11.15 Bard
11.15.1 Bard Company Details
11.15.2 Bard Business Overview
11.15.3 Bard Cardiovascular Prosthetic Products Introduction
11.15.4 Bard Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.15.5 Bard Recent Development
11.16 Jude Medical
11.16.1 Jude Medical Company Details
11.16.2 Jude Medical Business Overview
11.16.3 Jude Medical Cardiovascular Prosthetic Products Introduction
11.16.4 Jude Medical Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.16.5 Jude Medical Recent Development
11.17 LeMaitre Vascular
11.17.1 LeMaitre Vascular Company Details
11.17.2 LeMaitre Vascular Business Overview
11.17.3 LeMaitre Vascular Cardiovascular Prosthetic Products Introduction
11.17.4 LeMaitre Vascular Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.17.5 LeMaitre Vascular Recent Development
11.18 Lifetech Scientific
11.18.1 Lifetech Scientific Company Details
11.18.2 Lifetech Scientific Business Overview
11.18.3 Lifetech Scientific Cardiovascular Prosthetic Products Introduction
11.18.4 Lifetech Scientific Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.18.5 Lifetech Scientific Recent Development
11.19 BiVACOR
11.19.1 BiVACOR Company Details
11.19.2 BiVACOR Business Overview
11.19.3 BiVACOR Cardiovascular Prosthetic Products Introduction
11.19.4 BiVACOR Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.19.5 BiVACOR Recent Development
11.20 SynCardia
11.20.1 SynCardia Company Details
11.20.2 SynCardia Business Overview
11.20.3 SynCardia Cardiovascular Prosthetic Products Introduction
11.20.4 SynCardia Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.20.5 SynCardia Recent Development
11.21 Jarvik Heart, Inc
11.21.1 Jarvik Heart, Inc Company Details
11.21.2 Jarvik Heart, Inc Business Overview
11.21.3 Jarvik Heart, Inc Cardiovascular Prosthetic Products Introduction
11.21.4 Jarvik Heart, Inc Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.21.5 Jarvik Heart, Inc Recent Development
11.22 CARMAT
11.22.1 CARMAT Company Details
11.22.2 CARMAT Business Overview
11.22.3 CARMAT Cardiovascular Prosthetic Products Introduction
11.22.4 CARMAT Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.22.5 CARMAT Recent Development
11.23 AbioMed
11.23.1 AbioMed Company Details
11.23.2 AbioMed Business Overview
11.23.3 AbioMed Cardiovascular Prosthetic Products Introduction
11.23.4 AbioMed Revenue in Cardiovascular Prosthetic Products Business (2021–2026)
11.23.5 AbioMed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cardiovascular Prosthetic Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Cardiac Prosthetic Products
 Table 3. Key Players of Vascular Prosthetic Products
 Table 4. Global Cardiovascular Prosthetic Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Cardiovascular Prosthetic Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Cardiovascular Prosthetic Products Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Cardiovascular Prosthetic Products Market Share by Region (2021–2026)
 Table 8. Global Cardiovascular Prosthetic Products Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Cardiovascular Prosthetic Products Market Share by Region (2027–2032)
 Table 10. Cardiovascular Prosthetic Products Market Trends
 Table 11. Cardiovascular Prosthetic Products Market Drivers
 Table 12. Cardiovascular Prosthetic Products Market Challenges
 Table 13. Cardiovascular Prosthetic Products Market Restraints
 Table 14. Global Cardiovascular Prosthetic Products Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Cardiovascular Prosthetic Products Market Share by Players (2021–2026)
 Table 16. Global Top Cardiovascular Prosthetic Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cardiovascular Prosthetic Products Revenue, 2025
 Table 17. Ranking of Global Top Cardiovascular Prosthetic Products Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Cardiovascular Prosthetic Products Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Cardiovascular Prosthetic Products, Headquarters and Area Served
 Table 20. Global Key Players of Cardiovascular Prosthetic Products, Products and Applications
 Table 21. Global Key Players of Cardiovascular Prosthetic Products, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Cardiovascular Prosthetic Products Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Cardiovascular Prosthetic Products Revenue Market Share by Type (2021–2026)
 Table 25. Global Cardiovascular Prosthetic Products Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Cardiovascular Prosthetic Products Revenue Market Share by Type (2027–2032)
 Table 27. Global Cardiovascular Prosthetic Products Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Cardiovascular Prosthetic Products Revenue Market Share by Application (2021–2026)
 Table 29. Global Cardiovascular Prosthetic Products Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Cardiovascular Prosthetic Products Revenue Market Share by Application (2027–2032)
 Table 31. North America Cardiovascular Prosthetic Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Cardiovascular Prosthetic Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Cardiovascular Prosthetic Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Cardiovascular Prosthetic Products Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Cardiovascular Prosthetic Products Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Cardiovascular Prosthetic Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Cardiovascular Prosthetic Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Cardiovascular Prosthetic Products Market Size by Country (US$ Million), 2027–2032
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Cardiovascular Prosthetic Products Product
 Table 49. Abbott Laboratories Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 50. Abbott Laboratories Recent Development
 Table 51. B Braun Melsungen AG Company Details
 Table 52. B Braun Melsungen AG Business Overview
 Table 53. B Braun Melsungen AG Cardiovascular Prosthetic Products Product
 Table 54. B Braun Melsungen AG Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 55. B Braun Melsungen AG Recent Development
 Table 56. Boston Scientific Corporation Company Details
 Table 57. Boston Scientific Corporation Business Overview
 Table 58. Boston Scientific Corporation Cardiovascular Prosthetic Products Product
 Table 59. Boston Scientific Corporation Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 60. Boston Scientific Corporation Recent Development
 Table 61. Biotronic Company Details
 Table 62. Biotronic Business Overview
 Table 63. Biotronic Cardiovascular Prosthetic Products Product
 Table 64. Biotronic Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 65. Biotronic Recent Development
 Table 66. W. L. Gore & Associates, Inc Company Details
 Table 67. W. L. Gore & Associates, Inc Business Overview
 Table 68. W. L. Gore & Associates, Inc Cardiovascular Prosthetic Products Product
 Table 69. W. L. Gore & Associates, Inc Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 70. W. L. Gore & Associates, Inc Recent Development
 Table 71. Artivion, Inc Company Details
 Table 72. Artivion, Inc Business Overview
 Table 73. Artivion, Inc Cardiovascular Prosthetic Products Product
 Table 74. Artivion, Inc Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 75. Artivion, Inc Recent Development
 Table 76. Johnson and Johnson Company Details
 Table 77. Johnson and Johnson Business Overview
 Table 78. Johnson and Johnson Cardiovascular Prosthetic Products Product
 Table 79. Johnson and Johnson Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 80. Johnson and Johnson Recent Development
 Table 81. Medtronic Plc Company Details
 Table 82. Medtronic Plc Business Overview
 Table 83. Medtronic Plc Cardiovascular Prosthetic Products Product
 Table 84. Medtronic Plc Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 85. Medtronic Plc Recent Development
 Table 86. Meril Life Sciences Pvt. Ltd Company Details
 Table 87. Meril Life Sciences Pvt. Ltd Business Overview
 Table 88. Meril Life Sciences Pvt. Ltd Cardiovascular Prosthetic Products Product
 Table 89. Meril Life Sciences Pvt. Ltd Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 90. Meril Life Sciences Pvt. Ltd Recent Development
 Table 91. Edwards Lifesciences Company Details
 Table 92. Edwards Lifesciences Business Overview
 Table 93. Edwards Lifesciences Cardiovascular Prosthetic Products Product
 Table 94. Edwards Lifesciences Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 95. Edwards Lifesciences Recent Development
 Table 96. Terumo Group Company Details
 Table 97. Terumo Group Business Overview
 Table 98. Terumo Group Cardiovascular Prosthetic Products Product
 Table 99. Terumo Group Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 100. Terumo Group Recent Development
 Table 101. Maquet Cardiovascular Company Details
 Table 102. Maquet Cardiovascular Business Overview
 Table 103. Maquet Cardiovascular Cardiovascular Prosthetic Products Product
 Table 104. Maquet Cardiovascular Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 105. Maquet Cardiovascular Recent Development
 Table 106. Gore Company Details
 Table 107. Gore Business Overview
 Table 108. Gore Cardiovascular Prosthetic Products Product
 Table 109. Gore Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 110. Gore Recent Development
 Table 111. Nicast Company Details
 Table 112. Nicast Business Overview
 Table 113. Nicast Cardiovascular Prosthetic Products Product
 Table 114. Nicast Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 115. Nicast Recent Development
 Table 116. Bard Company Details
 Table 117. Bard Business Overview
 Table 118. Bard Cardiovascular Prosthetic Products Product
 Table 119. Bard Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 120. Bard Recent Development
 Table 121. Jude Medical Company Details
 Table 122. Jude Medical Business Overview
 Table 123. Jude Medical Cardiovascular Prosthetic Products Product
 Table 124. Jude Medical Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 125. Jude Medical Recent Development
 Table 126. LeMaitre Vascular Company Details
 Table 127. LeMaitre Vascular Business Overview
 Table 128. LeMaitre Vascular Cardiovascular Prosthetic Products Product
 Table 129. LeMaitre Vascular Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 130. LeMaitre Vascular Recent Development
 Table 131. Lifetech Scientific Company Details
 Table 132. Lifetech Scientific Business Overview
 Table 133. Lifetech Scientific Cardiovascular Prosthetic Products Product
 Table 134. Lifetech Scientific Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 135. Lifetech Scientific Recent Development
 Table 136. BiVACOR Company Details
 Table 137. BiVACOR Business Overview
 Table 138. BiVACOR Cardiovascular Prosthetic Products Product
 Table 139. BiVACOR Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 140. BiVACOR Recent Development
 Table 141. SynCardia Company Details
 Table 142. SynCardia Business Overview
 Table 143. SynCardia Cardiovascular Prosthetic Products Product
 Table 144. SynCardia Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 145. SynCardia Recent Development
 Table 146. Jarvik Heart, Inc Company Details
 Table 147. Jarvik Heart, Inc Business Overview
 Table 148. Jarvik Heart, Inc Cardiovascular Prosthetic Products Product
 Table 149. Jarvik Heart, Inc Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 150. Jarvik Heart, Inc Recent Development
 Table 151. CARMAT Company Details
 Table 152. CARMAT Business Overview
 Table 153. CARMAT Cardiovascular Prosthetic Products Product
 Table 154. CARMAT Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 155. CARMAT Recent Development
 Table 156. AbioMed Company Details
 Table 157. AbioMed Business Overview
 Table 158. AbioMed Cardiovascular Prosthetic Products Product
 Table 159. AbioMed Revenue in Cardiovascular Prosthetic Products Business (US$ Million), 2021–2026
 Table 160. AbioMed Recent Development
 Table 161. Research Programs/Design for This Report
 Table 162. Key Data Information from Secondary Sources
 Table 163. Key Data Information from Primary Sources
 Table 164. Authors List of This Report


List of Figures
 Figure 1. Cardiovascular Prosthetic Products Picture
 Figure 2. Global Cardiovascular Prosthetic Products Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Cardiovascular Prosthetic Products Market Share by Type: 2025 vs 2032
 Figure 4. Cardiac Prosthetic Products Features
 Figure 5. Vascular Prosthetic Products Features
 Figure 6. Global Cardiovascular Prosthetic Products Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Cardiovascular Prosthetic Products Market Share by Application: 2025 vs 2032
 Figure 8. Hospitals Case Studies
 Figure 9. Clinics Case Studies
 Figure 10. Others Case Studies
 Figure 11. Cardiovascular Prosthetic Products Report Years Considered
 Figure 12. Global Cardiovascular Prosthetic Products Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Cardiovascular Prosthetic Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Cardiovascular Prosthetic Products Market Share by Region: 2025 vs 2032
 Figure 15. Global Cardiovascular Prosthetic Products Market Share by Players in 2025
 Figure 16. Global Cardiovascular Prosthetic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Cardiovascular Prosthetic Products Revenue in 2025
 Figure 18. North America Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Cardiovascular Prosthetic Products Market Share by Country (2021–2032)
 Figure 20. United States Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Cardiovascular Prosthetic Products Market Share by Country (2021–2032)
 Figure 24. Germany Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Cardiovascular Prosthetic Products Market Share by Region (2021–2032)
 Figure 32. China Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Cardiovascular Prosthetic Products Market Share by Country (2021–2032)
 Figure 40. Mexico Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Cardiovascular Prosthetic Products Market Share by Country (2021–2032)
 Figure 44. Israel Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Cardiovascular Prosthetic Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Abbott Laboratories Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 48. B Braun Melsungen AG Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 49. Boston Scientific Corporation Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 50. Biotronic Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 51. W. L. Gore & Associates, Inc Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 52. Artivion, Inc Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 53. Johnson and Johnson Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 54. Medtronic Plc Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 55. Meril Life Sciences Pvt. Ltd Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 56. Edwards Lifesciences Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 57. Terumo Group Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 58. Maquet Cardiovascular Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 59. Gore Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 60. Nicast Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 61. Bard Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 62. Jude Medical Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 63. LeMaitre Vascular Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 64. Lifetech Scientific Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 65. BiVACOR Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 66. SynCardia Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 67. Jarvik Heart, Inc Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 68. CARMAT Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 69. AbioMed Revenue Growth Rate in Cardiovascular Prosthetic Products Business (2021–2026)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture